国产药物洗脱支架治疗冠心病九个月随访结果

目的：观察国产药物洗脱支架择期治疗冠心病的临床近、远期疗效。方法：2004年8月至2006年2月择期接受Firebird支架（雷帕霉素洗脱支架）治疗的265例冠心病患者，368支病变血管的401处相关病变置入421枚Firebird支架，随访9个月以上。结果：支架植入成功率100％，30天、6个月、9个月的严重心脏不良事件（包括死亡、再发心肌梗死、靶血管再成形等）分别为1．13％、1．51％、3．77％，血栓形成发生率为0，造影随访率32．01％，9个月的支架内再狭窄率为3．53％。结论：国产药物洗脱支架有良好的临床近、远期疗效。

Safety and efficacy of native drug-eluting stent in patients with coronary heart disease

Objective:To observe the recent and late clinical effects of native drug-eluting stents for treating coronary heart disease(CHD).Methods:Between August 2004 and February 2006,256 CHD patients underwent stents implantation,421 Firebird stents(rapamycin-eluting stents ) were implanted at 401 culprit lesions in 368vessels,followed-up for 9 months. Results:The rate of successful stent implantation was 100%. The rates of major adverse cardiovascular events (including death,reinfarction,and target-vessel revascularizations) were 1.13% on 30 days,1.51% on 6 months,and 3.77% on 9 months. The rate of thrombosis was 0 in these patients.The re-angiography of follow-up was 32.01% and restenosis was 3.53% in patients with stent implantation for 9 months. Conclusion:Native drug-eluting stents have favorable clinical recent and late clinical effects.